The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prophylactic cranial irradiation (PCI) versus observation in radically treated stage III non-small cell lung cancer (NSCLC): A randomized phase III NVALT11 study.
 
Harry J.M. Groen
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Research Funding - Lilly (Inst); Roche (Inst)
 
Anne-Marie C. Dingemans
Consulting or Advisory Role - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb; Clovis Oncology (Inst); Lilly (Inst); MSD Oncology (Inst); Pfizer; Roche/Genentech (Inst)
 
Jose Belderbos
No Relationships to Disclose
 
Caroline Tissing-Tan
No Relationships to Disclose
 
Gertruda Herder
No Relationships to Disclose
 
Tjeerd Haitjema
No Relationships to Disclose
 
Fred Ubbels
No Relationships to Disclose
 
Frank J Lagerwaard
No Relationships to Disclose
 
Sherif El Sharouni
No Relationships to Disclose
 
Jos Stigt
No Relationships to Disclose
 
Egbert F. Smit
Consulting or Advisory Role - Lilly
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Roche/Genentech (Inst)
 
Harm van Tinteren
No Relationships to Disclose
 
Vincent van de Noort
No Relationships to Disclose
 
Dirk De Ruysscher
No Relationships to Disclose